These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 8022175)

  • 21. Follow-up contact bias in evaluation of substance abuse treatment programs.
    Rohrer JE; Vaughan MS; Cadoret R; Zwick J
    Adm Policy Ment Health; 1999 Jan; 26(3):207-12. PubMed ID: 10339835
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Treatment of drug abuse syndromes.
    Halikas JA
    Psychiatr Clin North Am; 1993 Dec; 16(4):693-702. PubMed ID: 8309807
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Cannabis cessation interventions offered to young French users: predictors of follow-up].
    Abdoul H; Le Faou AL; Bouchez J; Touzeau D; Lagrue G
    Encephale; 2012 Apr; 38(2):141-8. PubMed ID: 22516272
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The effectiveness of treatment for substance abuse. Reasons for optimism.
    Miller WR
    J Subst Abuse Treat; 1992; 9(2):93-102. PubMed ID: 1512807
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Nicotine treatment at the Drug Dependency Program of the Minneapolis VA Medical Center. A researcher's perspective.
    Joseph AM
    J Subst Abuse Treat; 1993; 10(2):147-52. PubMed ID: 8389895
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Adolescent substance abuse. Recognition and early intervention.
    Muramoto ML; Leshan L
    Prim Care; 1993 Mar; 20(1):141-54. PubMed ID: 8464936
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Rehabilitation from substance abuse in individuals with a history of sexual abuse.
    Chiavaroli T
    J Subst Abuse Treat; 1992; 9(4):349-54. PubMed ID: 1336071
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Influence of retroactive disability payments on recipients' compliance with substance abuse treatment.
    Satel S; Reuter P; Hartley D; Rosenheck R; Mintz J
    Psychiatr Serv; 1997 Jun; 48(6):796-9. PubMed ID: 9175188
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Health indicators of substance abuse problems in Baltimore.
    DeWeese J; Liu H
    Md Med J; 1993 Aug; 42(8):751-9. PubMed ID: 8412536
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison between treatment completers and noncompleters among dually diagnosed substance-abusing adolescents.
    Kaminer Y; Tarter RE; Bukstein OG; Kabene M
    J Am Acad Child Adolesc Psychiatry; 1992 Nov; 31(6):1046-9. PubMed ID: 1429403
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Treatment goals in addiction healthcare: the perspectives of patients and clinicians.
    Joosten EA; De Weert-Van Oene GH; Sensky T; Van Der Staak CP; De Jong CA
    Int J Soc Psychiatry; 2011 May; 57(3):263-76. PubMed ID: 20068024
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The impact of social support and self-esteem on adolescent substance abuse treatment outcome.
    Richter SS; Brown SA; Mott MA
    J Subst Abuse; 1991; 3(4):371-85. PubMed ID: 1668229
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Reliability of adolescent self-reported pretreatment alcohol and other drug use.
    Stinchfield R
    Subst Use Misuse; 1997 Mar; 32(4):425-34. PubMed ID: 9090804
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Dual diagnosis.
    Turnbull JM; Roszell DK
    Prim Care; 1993 Mar; 20(1):181-90. PubMed ID: 8464939
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Public policy statement on recommendations for design of treatment efficacy research with emphasis on outcome measures.
    J Addict Dis; 1994; 13(1):119-24. PubMed ID: 8018736
    [No Abstract]   [Full Text] [Related]  

  • 36. Validity of the SCID in substance abuse patients.
    Kranzler HR; Kadden RM; Babor TF; Tennen H; Rounsaville BJ
    Addiction; 1996 Jun; 91(6):859-68. PubMed ID: 8696248
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Measuring substance abuse program treatment orientations: the Drug and Alcohol Program Treatment Inventory.
    Swindle RW; Peterson KA; Paradise MJ; Moos RH
    J Subst Abuse; 1995; 7(1):61-78. PubMed ID: 7655312
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Reducing waiting time for substance abuse treatment does not reduce attrition.
    Alterman AI; Bedrick J; Howden D; Maany I
    J Subst Abuse; 1994; 6(3):325-32. PubMed ID: 7703709
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Contrasting predictors of readiness for substance abuse treatment in adults and adolescents: a latent variable analysis of DATOS and DATOS-A participants.
    Handelsman L; Stein JA; Grella CE
    Drug Alcohol Depend; 2005 Oct; 80(1):63-81. PubMed ID: 15894434
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Characteristics of patients with substance abuse diagnoses on a general psychiatry unit in a VA Medical Center.
    Lambert MT; Griffith JM; Hendrickse W
    Psychiatr Serv; 1996 Oct; 47(10):1104-7. PubMed ID: 8890339
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.